Plasma total homocysteine concentrations in a Turkish population sample

Acta Cardiologica

Volumn 64, Issue 2, 2009, Pages 247-251

  Yaman, Halil ^a   Akgul, Emin O ^a   Kurt, Yasemin G ^a   Cakir, Erdinc ^a   Gocgeldi, Ercan ^a   Kunak, Zeki I ^a   Macit, Enis ^a   Cayci, Tuncer ^a   Erbil, Mehmet K ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Age; Plasma total homocysteine concentrations; Turkish men and women

Indexed keywords

HOMOCYSTEINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; EUROPE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK POPULATION; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; RACE DIFFERENCE; REFERENCE VALUE; SEX DIFFERENCE; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INCIDENCE; INFANT; MALE; MIDDLE AGED; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEX FACTORS; TURKEY; YOUNG ADULT;

EID: 65349136964     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.64.2.2036145     Document Type: Article

References (20)

1. Molero AE, Altimari CC, Duran DA, Garcia E, Pino-Ramirez G, Maestre GE. Total plasma homocysteine values among elderly subjects: findings from the Maracaibo Aging Study. Clin Biochem 2006; 39: 1007-15.
2. Taskin G, Yilmaz Sipahi E, Yildirimkaya M, Nadirler F, Halloran M, Ayoglu FN, Laleli Y. Plasma total homocysteine levels in a healthy Turkish population sample. Acta Cardiol 2006; 61: 35-42.
3. Ganji V, Kafai MR. Population references for plasma total homocysteine concentrations for U.S. children and adolescents in the post-folic acid fortification era. J Nutr 2005; 135: 2253-6.
4. Golbahar J, Rezaian G, Bararpour H. Distribution of plasma total homocysteine concentrations in the healthy Iranians. Clin Biochem 2004; 37: 149-51.
5. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005; 82: 442-50.
6. Papandreou D, Mavromichalis I, Makedou A, Rousso I, Arvanitidou M. Total serum homocysteine, folate and vitamin B12 in a Greek school age population. Clin Nutr 2006; 25: 797-802.
7. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstorm LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwall CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Ruoland FM, Tan KS, Higgins I, Garcon D, Andria G. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-81.
8. Alfthan G, Aro A, Gey KF. Plasma homocysteine and cardiovascular disease mortality. Lancet 1997; 349: 397.
9. Henriquez P, Doreste J, Deulofeu R, Fiuza MD, Serra-Majem L. Nutritional determinants of plasma total homocysteine distribution in the Canary Islands. Eur J Clin Nutr 2007; 61: 111-8.
10. Selhub J, Jacques PF. Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999; 131: 331-9.
11. Alfthan G, Laurinen MS, Valsta LM, Pastinen T, Aro A. Folate intake, plasma folate and homocysteine status in a random Finnish population. Eur J Clin Nutr 2003; 57: 81-8.
12. Nurk E, Tell GS, Vollset SE, Nygard O, Refsum H, Ueland PM. Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study. Arch Intern Med 2002; 162: 1374-81.
13. Nygard O, Vollset SE, Refsum H. Plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 1995; 274: 1526-33.
14. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-75.
15. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998; 49: 31-62.
16. Christen WG, Ajani UA, Glynn RJ, Henekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 2000; 160: 422-34.
17. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-50.
18. Moghadasian MH, McManus BM, Frohlich JJ. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background. Arch Intern Med 1997; 157: 2299-308.
19. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluljtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
20. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 1997; 78: 523-6.